EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $90,146 | +0.8% | 10,953 | -11.2% | 0.01% | 0.0% |
| Q1 2023 | $89,461 | -19.8% | 12,339 | -1.9% | 0.01% | -28.6% |
| Q4 2022 | $111,558 | -32.4% | 12,577 | -6.5% | 0.01% | -46.2% |
| Q3 2022 | $165,000 | -39.3% | 13,458 | +103.1% | 0.01% | -40.9% |
| Q3 2021 | $272,000 | -54.5% | 6,626 | -37.3% | 0.02% | -42.1% |
| Q2 2021 | $598,000 | +56.5% | 10,560 | +16.0% | 0.04% | +40.7% |
| Q1 2021 | $382,000 | -33.7% | 9,102 | +10.9% | 0.03% | -43.8% |
| Q4 2020 | $576,000 | +9500.0% | 8,210 | +3924.5% | 0.05% | +2300.0% |
| Q1 2018 | $6,000 | +50.0% | 204 | +56.9% | 0.00% | +100.0% |
| Q4 2017 | $4,000 | +33.3% | 130 | +16.1% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | -97.2% | 112 | +60.0% | 0.00% | -98.1% |
| Q2 2017 | $107,000 | – | 70 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |